5α-Reductase Inhibitors and Risk of High-Grade or Lethal Prostate Cancer: Preston MA, Wilson KM, Markt SC, et al (Massachusetts General Hosp, Boston; Harvard School of Public Health, Boston, MA) JAMA Intern Med 2014 [Epub ahead of print]§
Publication date: 2014Source: Yearbook of Urology, Volume 2014Author(s): G.L. Andriole
Source: Yearbook of Urology - Category: Urology & Nephrology Source Type: research
More News: Cancer | Cancer & Oncology | Harvard | International Medicine & Public Health | Prostate Cancer | Urology & Nephrology